FibroBiologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4.89	13.99	9.16	2.27	0.41
Cash & Short-Term Investments	4.89	13.99	9.16	2.27	0.41
Cash Growth	-65.00%	52.63%	304.37%	456.76%	-
Other Current Assets	1.46	0.24	0.05	0.36	0.06
Total Current Assets	6.35	14.23	9.22	2.63	0.47
Net Property, Plant & Equipment	3.22	2.22	2.19	2.2	-
Other Long-Term Assets	0.05	-	-	-	-
Total Assets	9.62	16.45	11.82	4.82	0.47
Accounts Payable	0.95	2.7	1.44	0.76	0.23
Short-Term Debt	-	0.4	-	5.45	1.3
Current Portion of Leases	0.71	0.46	0.36	0.33	-
Other Current Liabilities	0.11	9.17	7.38	0.54	0.23
Total Current Liabilities	1.76	12.73	9.18	7.07	1.76
Long-Term Leases	1.7	0.98	1.39	1.75	-
Total Long-Term Liabilities	1.7	0.98	1.39	1.75	-
Total Liabilities	3.46	13.71	10.57	8.82	1.76
Common Stock	-	-	-	0	-
Total Common Shareholders' Equity	-	-	-	0	-
Minority Interest	-	-	-	1.46	1.46
Shareholders' Equity	-	-	-	1.46	1.46
Total Liabilities & Equity	9.62	16.45	11.82	4.82	0.47
Total Debt	2.41	1.85	1.75	7.52	1.3
Net Cash (Debt)	2.48	12.14	7.42	-5.26	-0.89
Net Cash Growth	-79.54%	63.70%	-	-	-
Net Cash Per Share	0.06	0.37	0.26	-	-
Book Value	0	0	0	0	0
Tangible Book Value	0	0	0	0	0

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q